Patents by Inventor Johnson MAK

Johnson MAK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY
    Publication number: 20260191879
    Abstract: A method of treating an infection with a pathogen in a subject infected with the pathogen, wherein the pathogen is a Neisseria species or a retrovirus that interacts with a complement receptor 3 (CR3) polypeptide of a CR3 polypeptide-expressing cell, the method comprising administering to the subject an effective amount of a dibenzoazepine compound as disclosed.
    Type: Application
    Filed: March 2, 2026
    Publication date: July 9, 2026
    Inventors: Michael P. JENNINGS, Jennifer L. EDWARDS, Christopher J. DAY, Johnson MAK
  • Agents and methods for modulating pathogen activity
    Patent number: 12564596
    Abstract: Ligands of complement receptor 3, including ligands of the I domain of the alpha subunit of this receptor, are useful in methods, compositions and articles/devices for inhibiting the interaction of pathogens to a complement receptor 3-expressing cell and for treating or inhibiting the development of infections caused by such pathogens.
    Type: Grant
    Filed: September 30, 2019
    Date of Patent: March 3, 2026
    Assignees: Griffith University, Research Institute at Nationwide Children's Hospital
    Inventors: Michael P. Jennings, Jennifer L. Edwards, Christopher J. Day, Johnson Mak
  • AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY
    Publication number: 20210338685
    Abstract: The present disclosure relates to the use of ligands of complement receptor 3, including ligands of the I domain of the alpha subunit of this receptor, in methods, compositions and articles/devices for inhibiting the interaction of pathogens to a complement receptor 3-expressing cell and for treating or inhibiting the development of infections caused by such pathogens.
    Type: Application
    Filed: September 30, 2019
    Publication date: November 4, 2021
    Inventors: Michael P. JENNINGS, Jennifer L. EDWARDS, Christopher J. DAY, Johnson MAK